Assessment of Newly Synthesized Triazole Compounds Using ZnO(NPs) as Antimicrobial Agents and Theoretical Studies for Inhibiting COVID-19

References

• N. D. Rode, A. D. Sonawane, L. Nawale, V. M. Khedkar, R. A. Joshi, A. P. Likhite, D. Sarkar, and R. R. Joshi, “Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 3-Aryl-5-(Alkyl-Thio)-1H-1,2,4-Triazoles Derivatives Targeting Mycobacterium Tuberculosis,” Chemical Biology & Drug Design 90, no. 6 (2017): 1206–14. doi:10.1111/cbdd.13040
   PubMed Web of Science ®Google Scholar
• Hülya Karaca Gençer, Ulviye Acar Çevik, Serkan Levent, Begüm Sağlık, Büşra Korkut, Yusuf Özkay, Sinem Ilgın, and Yusuf Öztürk, “New Benzimidazole 1,2,4-Triazole Hybrid Compounds: Synthesis, Anticandidal Activity and Cytotoxicity Evaluation,” Molecules 22, no. 4 (2017): 507. doi:10.3390/molecules22040507
   PubMed Web of Science ®Google Scholar
• N. R. Appna, R. K. Nagiri, R. B. Korupolu, S. Kanugala, G. K. Chityal, G. Thipparapu, and N. Banda, “Design and Synthesis of Novel 4-Hydrazone Functionalized/1,2,4-Triazole Fused Pyrido[2,3-d]Pyrimidine Derivatives, Their Evaluation for Antifungal Activity and Docking Studies,” Medicinal Chemistry Research 28, no. 9 (2019): 1509–28. doi:10.1007/s00044-019-02390-w
   Web of Science ®Google Scholar
• Z. Peng, G. Wang, Q. H. Zeng, Y. Li, Y. Wu, H. Liu, J. J. Wang, and Y. Zhao, “Synthesis, Antioxidant and anti-Tyrosinase Activity of 1,2,4-Triazole Hydrazones as Antibrowning Agents,” Food Chemistry 341, no. Pt 2 (2021): 128265. doi:10.1016/j.foodchem.2020.128265
   PubMedGoogle Scholar
• Sin-Min Li, Shuo-En Tsai, Chia-Yin Chiang, Cheng-Yen Chung, Tsung-Jui Chuang, Ching-Chun Tseng, Wen-Ping Jiang, Guan-Jhong Huang, Chin-Yu Lin, Ya-Chen Yang, et al, “New Methyl 5-(Halomethyl)-1-Aryl-1H-1,2,4-Triazole-3-Carboxylates as Selective COX-2 Inhibitors and anti-Inflammatory Agents: Design, Synthesis, Biological Evaluation, and Docking Study,” Bioorganic Chemistry 104 (2020): 104333. doi:10.1016/j.bioorg.2020.104333
   PubMed Web of Science ®Google Scholar
• O. Grytsai, O. Valiashko, M. Penco-Campillo, M. Dufies, A. Hagege, L. Demange, S. Martial, G. Pagès, C. Ronco, and R. Benhida, “Synthesis and Biological Evaluation of 3-Amino-1,2,4-Triazole Derivatives as Potential Anticancer Compounds,” Bioorganic Chemistry 104 (2020): 104271. doi:10.1016/j.bioorg.2020.104271
   PubMed Web of Science ®Google Scholar
• F. Hichri, A. Omri, A. S. M. Hossan, and H. Ben Jannet, “Alpha-Glucosidase and Amylase Inhibitory Effects of Eruca Vesicaria Subsp. Longirostris Essential Oils: Synthesis of New 1,2,4-Triazole-Thiol Derivatives and 1,3,4-Thiadiazole with Potential Inhibitory Activity,” Pharmaceutical Biology 57, no. 1 (2019): 564–70. doi:10.1080/13880209.2019.1642363
   PubMed Web of Science ®Google Scholar
• S. G. Khanage, A. Raju, P. B. Mohite, and R. B. Pandhare, “Analgesic Activity of Some 1,2,4-Triazole Heterocycles Clubbed with Pyrazole, Tetrazole, Isoxazole and Pyrimidine,” Adv. Pharm. Bull 3 (2013): 13–8.
   PubMedGoogle Scholar
• L. Navidpour, S. Shabani, A. Heidari, M. Bashiri, A. Ebrahim-Habibi, S. Shahhosseini, H. Shafaroodi, S. Abbas Tabatabai, and M. Toolabi, “5-[Aryloxypyridyl (or Nitrophenyl)]-4H-1,2,4-Triazoles as Novel Flexible Benzodiazepine Analogues: Synthesis, Receptor Binding Affinity and Lipophilicity-Dependent anti-Seizure Onset of Action,” Bioorganic Chemistry 106 (2021): 104504. doi:10.1016/j.bioorg.2020.104504
   PubMed Web of Science ®Google Scholar
• B. Kaproń, J. J. Łuszczki, A. Siwek, T. Karcz, G. Nowak, M. Zagaja, M. Andres-Mach, A. Stasiłowicz, J. Cielecka-Piontek, J. Kocki, et al, “Preclinical Evaluation of 1,2,4-Triazole-Based Compounds Targeting Voltage-Gated Sodium Channels (VGSCs) as Promising Anticonvulsant Drug Candidates,” Bioorganic Chemistry. 94 (2020): 103355. doi:10.1016/j.bioorg.2019.103355
   PubMed Web of Science ®Google Scholar
• M. Monod, “Secreted Proteases from Dermatophytes,” Mycopathologia 166, no. 5-6 (2008): 285–94. doi:10.1007/s11046-008-9105-4
   PubMed Web of Science ®Google Scholar
• N. M. Martinez-Rossi, N. T. A. Peres, and A. Rossi, “Antifungal Resistance Mechanisms in Dermatophytes,” Mycopathologia 166, no. 5-6 (2008): 369–83. doi:10.1007/s11046-008-9110-7
   PubMed Web of Science ®Google Scholar
• A. H. Holmes, L. S. P. Moore, A. Sundsfjord, M. Steinbakk, S. Regmi, A. Karkey, P. J. Guerin, and L. J. V. Piddock, “Understanding the Mechanisms and Drivers of Antimicrobial Resistance,” Lancet (London, England) 387, no. 10014 (2016): 176–87. doi:10.1016/S0140-6736(15)00473-0
   PubMed Web of Science ®Google Scholar
• E. Palma, B. Tilocca, and P. Roncada, “Antimicrobial Resistance in Veterinary Medicine: An Overview,” International Journal of Molecular Sciences 21, no. 6 (2020): 1914. doi:10.3390/ijms21061914
   PubMed Web of Science ®Google Scholar
• M. G. Donadu, N. T. Le, D. V. Ho, T. Q. Doan, A. T. Le, A. Raal, M. Usai, M. Marchetti, G. Sanna, S. Madeddu, et al, “Phytochemical Compositions and Biological Activities of Essential Oils from the Leaves, Rhizomes and Whole Plant of Hornstedtia Bella Škorniˇck,” Antibiotics 9, no. 6 (2020): 334. doi:10.3390/antibiotics9060334
   Web of Science ®Google Scholar
• M. Strzelecka, and P. Świątek, “1,2,4-Triazoles as Important Antibacterial Agents,” Pharmaceuticals 14, no. 3 (2021): 224. doi:10.3390/ph14030224
   Web of Science ®Google Scholar
• Y. Diab, K. Atalla, and K. Elbanna, “Antimicrobial Screening of Some Egyptian Plants and Active Flavones from Lagerstroemia Indica Leaves,” Drug Discoveries & Therapeutics 6, no. 4 (2012): 212–7.
   PubMedGoogle Scholar
• K. Elbanna, A. M. A. Assiri, M. Tadros, M. Khider, A. Assaeedi, A. Mohdaly, and M. F. Ramadan, “Rosemary (Rosmarinus Officinalis) Oil: composition and Functionality of the Cold-Pressed Extract,” Journal of Food Measurement and Characterization 12, no. 3 (2018): 1601–9. doi:10.1007/s11694-018-9775-7
   Web of Science ®Google Scholar
• (a) D. Dixit, P. K. Verma, and R. K. Marwaha, “A Review on ‘Triazoles’: their Chemistry, Synthesis and Pharmacological Potentials,” Journal of the Iranian Chemical Society 18, no. 10 (2021): 2535–65. doi:10.1007/s13738-021-02231-x.
   Web of Science ®Google Scholar
  (b) A. S. A. Almalki, S. Nazreen, S. E. I. Elbehairi, M. Asad, A. A. Shati, M. Y. Alfaifi, A. Alhadhrami, A. A. Elhenawy, A. Q. Alorabi, A. M. Asiri, et al, “Design, Synthesis, Anticancer Activity and Molecular Docking Studies of New Benzimidazole Derivatives Bearing 1,3,4-Oxadiazole Moieties as Potential Thymidylate Synthase Inhibitors,” New Journal of Chemistry 46, no. 31 (2022): 14967–78. doi:10.1039/D2NJ01980A.
   Web of Science ®Google Scholar
  (c) S. A. S. Alzahrani, S. Nazreen, A. A. Elhenawy, A. Ahmad, and M. M. Alam, “Benzimidazole-1,3,4-Oxadiazole Hybrids: Synthesis, Anticancer Evaluation, Docking and DFT Studies,” Chemistry Selects 7 (2022): e202201559.
   Google Scholar
  (d) S. A. S. Alzahrani, S. Nazreen, A. A. Elhenawy, T. Neamatallah, and M. Mahboob, “Synthesis, Biological Evaluation, and Molecular Docking of New Benzimidazole-1,2,3-Triazole Hybrids as Antibacterial and Antitumor Agents,” Polycyclic Aromatic Compounds (2022) doi:10.1080/10406638.2022.2069133
   Google Scholar
• J. Albadi, M. Keshavarz, M. Abedini, and M. Khoshakhlagh, “Copper Iodide Nanoparticles on Poly(4-Vinylpyridine): a New and Efficient Catalyst for the Synthesis of 1,8-Dioxooctahydroxanthenes under Solvent-Free Conditions,” Journal of Chemical Sciences 125, no. 2 (2013): 295–8. doi:10.1007/s12039-013-0368-z
   Web of Science ®Google Scholar
• S. A. Sarode, J. M. Bhojane, and J. M. Nagarkar, “An Efficient Magnetic Copper Ferrite Nanoparticle: For One Pot Synthesis of 2-Substituted Benzoxazole via Redox Reactions,” Tetrahedron Letters. 56, no. 1 (2015): 206–10. doi:10.1016/j.tetlet.2014.11.065
   Web of Science ®Google Scholar
• D. H. Dawood, E. M. H. Abbas, T. A. Farghaly, M. M. Ali, and M. F. Ibrahim, “ZnO Nanoparticles Catalyst in Synthesis of Bioactive Fused Pyrimidines as anti-Breast Cancer Agents Targeting VEGFR-2,” Medicinal Chemistry (Shariqah (United Arab Emirates)) 15, no. 3 (2019): 277–86. doi:10.2174/1573406414666180912113226
   PubMed Web of Science ®Google Scholar
• J. Safaei-Ghomi, M. A. Ghasemzadeh, and S. Zahedi, "ZnO nanoparticles: A highly effective and readily recyclable catalyst for the one-pot synthesis 0f 1,8-dioxodecahydroacridine and 1,8-dioxooctahydro-xanthene derivatives." Journal of the Mexican Chemical Society 57, no. 1 (2013): 1–7.
   Web of Science ®Google Scholar
• Z. A. Muhammad, T. A. Farghaly, I. Althagafi, S. A. Al-Hussain, M. E. A. Zaki, and M. F. Harras, “Synthesis of Antimicrobial Azoloazines and Molecular Docking for Inhibiting COVID-19,” Journal of Heterocyclic Chemistry 58, no. 6 (2021): 1286–301. doi:10.1002/jhet.4257
   PubMed Web of Science ®Google Scholar
• Thoraya A. Farghaly, Ismail Althagafi, Mona H. Ibrahim, Nadia T. Al-Qurashi, and Umar Farooq, “Synthesis under Microwaves Irradiation, Structure Elucidation, Docking Study for Inhibiting COVID-19 and DFT Calculations of Novel Azoles Incorporated Indole Moiety,” Journal of Molecular Structure 1244 (2021): 131263. doi:10.1016/j.molstruc.2021.131263
   Web of Science ®Google Scholar
• M. Negi, P. A. Chawla, A. Faruk, and V. Chawla, “Role of Heterocyclic Compounds in SARS and SARS CoV-2 Pandemic,” Bioorganic Chemistry 104 (2020): 104315. doi:10.1016/j.bioorg.2020.104315
   PubMed Web of Science ®Google Scholar
• M. R. Aouad, D. J. O. Khan, M. A. Said, N. S. Al-Kaff, N. Rezki, A. A. Ali, N. Bouqellah, and M. Hagar, “Novel 1,2,3-Triazole Derivatives as Potential Inhibitors against Covid-19 Main Protease: Synthesis, Characterization, Molecular Docking and DFT Studies,” ChemistrySelect 6, no. 14 (2021): 3468–86. doi:10.1002/slct.202100522
   PubMed Web of Science ®Google Scholar
• Alaa M. A. Alnaja, Thoraya A. Farghaly, Heba S. A. El-Zahabi, and Mohamed R. Shaaban, “Cytotoxicity, Docking Study of New Fluorinated Fused Pyrimidine Scaffold: Thermal and Microwave Irradiation Synthesis,” Medicinal Chemistry (Shariqah (United Arab Emirates)) 17, no. 5 (2021): 501–18. doi:10.2174/1573406416666191216120301
   PubMed Web of Science ®Google Scholar
• Z. A. Muhammad, T. A. Farghaly, I. Althagafi, S. A. Al‐Hussain, M. E. A. Zaki, and M. F. Harras, “Synthesis of Antimicrobial Azoloazines and Molecular Docking for Inhibiting COVID‐19,” Journal of Heterocyclic Chemistry 58 (2021): 1286-1301. doi:10.1002/jhet.4257
   PubMed Web of Science ®Google Scholar
• H. K. Mahmoud, T. A. Farghaly, H. G. Abdulwahab, N. T. Al-Qurashi, and M. R. Shaaban, “Novel 2-Indolinone Thiazole Hybrids as Sunitinib Analogues: Design, Synthesis, and Potent VEGFR-2 Inhibition with Potential anti-Renal Cancer Activity,” European Journal of Medicinal Chemistry 208 (2020): 112752. doi:10.1016/j.ejmech.2020.112752
   PubMed Web of Science ®Google Scholar
• S. A. Al-Hussain, T. A. Farghaly, M. E. A. Zaki, H. G. Abdulwahab, N. T. Al-Qurashi, and Z. A. Muhammad, “Discovery of Novel Indolyl-1,2,4-Triazole Hybrids as Potent Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Inhibitors with Potential anti-Renal Cancer Activity,” Bioorganic Chemistry 105 (2020): 104330. doi:10.1016/j.bioorg.2020.104330
   PubMed Web of Science ®Google Scholar
• M. A. Omar, G. S. Masaret, E. M. H. Abbas, M. M. Abdel-Aziz, M. F. Harras, and T. A. Farghaly, “Novel anti-Tubercular and Antibacterial Based Benzosuberone-Thiazole Moieties: Synthesis, Molecular Docking Analysis, DNA Gyrase Supercoiling and ATPase Activity,” Bioorganic Chemistry 104 (2020): 104316. doi:10.1016/j.bioorg.2020.104316
   PubMed Web of Science ®Google Scholar
• H. K. Mahmoud, H. A. Katouah, M. F. Harras, and T. A. Farghaly, “A New Reactive Ketenaminal: Synthesis, Coupling Reaction, Tautomeric Study, Docking and Antimicrobial Evaluation of the Products,” Medicinal Chemistry (Shariqah (United Arab Emirates)) 16, no. 6 (2020): 761–73. doi:10.2174/1573406415666190716153425
   PubMed Web of Science ®Google Scholar
• T. A. Farghaly, G. S. Masaret, Z. A. Muhamm, and M. F. Harras, “Discovery of Thiazole-Based-Chalcones and 4-Hetarylthiazoles as Potent Anticancer Agents: Synthesis, Docking Study and Anticancer Activity,” Bioorganic Chemistry 98 (2020): 103761. doi:10.1016/j.bioorg.2020.103761
   PubMed Web of Science ®Google Scholar
• M. Chen, X. Wang, S. Wang, Y. Feng, F. Chen, and C. Yang, “Synthesis, Characterization and Fungicidal Activities of Novel Fluorinated 3,5-Disubstituted-4H-1,2,4-Triazol-4-Amines,” Journal of Fluorine Chemistry. 135 (2012): 323–9. doi:10.1016/j.jfluchem.2011.12.015
   Web of Science ®Google Scholar
• S. R. Attar, B. Shinde, and S. B. Kamble, “Enhanced Catalytic Activity of Bio-Fabricated ZnO NPs Prepared by Ultrasound-Assisted Route for the Synthesis of Tetraketone and Benzylidenemalonitrile in Hydrotropic Aqueous Medium,” Research on Chemical Intermediates 46, no. 10 (2020): 4723–48. doi:10.1007/s11164-020-04233-5
   Web of Science ®Google Scholar
• V. Duraipandiyan, and S. Ignacimuthu, “Antibacterial and Antifungal Activity of Flindersine Isolated from the Traditional Medicinal Plant, Toddalia Asiatica (L.) Lam,” Journal of Ethnopharmacology 123, no. 3 (2009): 494–8. doi:10.1016/j.jep.2009.02.020
   PubMed Web of Science ®Google Scholar
• S. N. Dighe, and T. A. Collet, “Recent Advances in DNA Gyrase-Targeted Antimicrobial Agents,” European Journal of Medicinal Chemistry 199 (2020): 112326. doi:10.1016/j.ejmech.2020.112326
   PubMed Web of Science ®Google Scholar
• R. Kaur, A. R. Dwivedi, B. Kumar, and V. Kumar, “Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A Review,” Anti-Cancer Agents in Medicinal Chemistry 16, no. 4 (2016): 465–89. doi:10.2174/1871520615666150819121106
   PubMed Web of Science ®Google Scholar
• T. Chatterjee, B. K. Chatterjee, D. Majumdar, and P. Chakrabarti, “Antibacterial Effect of Silver Nanoparticles and the Modeling of Bacterial Growth Kinetics Using a Modified Gompertz Model,” Biochimica et Biophysica Acta (Bba) - General Subjects 1850, no. 2 (2015): 299–306. doi:10.1016/j.bbagen.2014.10.022
   PubMed Web of Science ®Google Scholar
• E. Ruppé, P.-L. Woerther, and F. Barbier, “Mechanisms of Antimicrobial Resistance in Gram-Negative Bacilli,” Ann. Intensiv. Care 5 (2015): 61. doi:10.1186/s13613-015-0061-0
   PubMed Web of Science ®Google Scholar
• M. Exner, S. Bhattacharya, B. Christiansen, J. Gebel, P. Goroncy-Bermes, P. Hartemann, P. Heeg, C. Ilschner, A. Kramer, and E. Larson, “Antibiotic Resistance: What is so Special about Multidrug-Resistant Gram-Negative Bacteria? GMS Hyg,” Infect. Control 12 (2017): 1–24. doi:10.3205/dgkh000290
   Google Scholar
• Z. Breijyeh, B. Jubeh, and R. Karaman, “Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It,” Molecules 25, no. 6 (2020): 1340–Published 2020 Mar 16. doi:10.3390/molecules25061340
   PubMed Web of Science ®Google Scholar
• L. Ostrosky-Zeichner, A. Casadevall, J. N. Galgiani, F. C. Odds, and J. H. Rex, “An Insight into the Antifungal Pipeline: Selected New Molecules and Beyond,” Nature Reviews. Drug Discovery 9, no. 9 (2010): 719–27.
   PubMed Web of Science ®Google Scholar
• P. Calligari, S. Bobone, G. Ricci, and A. Bocedi, “Molecular Investigation of SARS–CoV-2 Proteins and Their Interactions with Antiviral Drugs,” Viruses 12, no. 4 (2020): 445. doi:10.3390/v12040445
   PubMed Web of Science ®Google Scholar
• P. Sang, S. Tian, Z. Meng, and L. Yang, “Anti-HIV Drug Repurposing against SARS-CoV-2,” RSC Advances 10, no. 27 (2020): 15775–83. doi:10.1039/D0RA01899F
   PubMed Web of Science ®Google Scholar
• A. Daina, O. Michielin, and V. Zoete, “Swiss ADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules,” Scientific Reports 7, no. 1 (2017): 1–13. doi:10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• M. J. Waring, “Defining Optimum Lipophilicity and Molecular Weight Ranges for Drug Candidates—Molecular Weight Dependent Lower Log D Limits Based on Permeability,” Bioorganic & Medicinal Chemistry Letters 19, no. 10 (2009): 2844–51. doi:10.1016/j.bmcl.2009.03.109
   PubMed Web of Science ®Google Scholar
• P. Ertl, B. Rohde, and P. Selzer, “Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties,” Journal of Medicinal Chemistry 43, no. 20 (2000): 3714–7. doi:10.1021/jm000942e
   PubMed Web of Science ®Google Scholar
• Jason D. Hughes, Julian Blagg, David A. Price, Simon Bailey, Gary A. Decrescenzo, Rajesh V. Devraj, Edmund Ellsworth, Yvette M. Fobian, Michael E. Gibbs, Richard W. Gilles, et al, “Physiochemical Drug Properties Associated with in Vivo Toxicological Outcomes,” Bioorganic & Medicinal Chemistry Letters 18, no. 17 (2008): 4872–5., doi:10.1016/j.bmcl.2008.07.071
   PubMed Web of Science ®Google Scholar
• A. W. Bauer, W. M. Kirby, J. C. Sherris, and M. Turck, “Antibiotic Susceptibility Testing by a Standardized Single Disk Method,” American Journal of Clinical Pathology 45, no. 4_ts (1966): 493–6. doi:10.1093/ajcp/45.4_ts.493
   PubMed Web of Science ®Google Scholar
• C.C.G. Inc., Molecular operating environment (MOE) 2014.09, Chemical Computing Group Inc., 1010 Sherbrooke Street West, Suite 910, Montréal, H3A 2R7, Canada, 2016.
   Google Scholar